Stada Group
Torsten Dickmann is a seasoned professional in intellectual property management with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as Senior Patent Manager at STADA Group since September 2022, Dickmann previously held the position of IP Counsel at Ascendis Pharma and worked as a Patent Attorney at Merz Pharmaceuticals and Dickmann Patent Law Firm. Training in patent law was completed at the German Federal Patent Court, the German Patent and Trademark Office, and the District Court Mannheim. Early career roles include Patent Manager and Patent Attorney Training at Stürken Patent Law Firm, as well as positions in product management and sales at CellGenix, GmbH, and ScheBo Biotech AG. Torsten Dickmann holds a Master’s degree in Biology from Albert-Ludwigs-Universität Freiburg and the University of St. Andrews, with a focus on biochemistry, cell biology, molecular biology, and philosophy.
This person is not in the org chart
This person is not in any teams
Stada Group
14 followers
Stada Arzneimittel AG is a Germany-based holding company active in the pharmaceutical sector and healthcare market. The Company develops and markets products with off-patent active pharmaceutical ingredients. The Company’s primary business segments are Generics and Branded Products. The Generics segment comprises low-priced and active-ingredient products. The Branded Products segment focuses on multisource products accessible without active ingredient research, notably anti-enzymatic food intolerance drugs that are marketed by the subsidiary SCIOTEC Diagnostics Technologies. The Company's generic drugs are marketed by the Group subsidiary, STADApharm GmbH. Non-core activities of the Company encompass Commercial Business segment, which includes activities with primarily trading character such as wholesaling activities. The Company operates STADA Pharmaceuticals Australia Pty Ltd and STADA IT SOLUTIONS DOO as subsidiaries.